SCTO Tools & Resources Navigator

Area of interest:
Select an area of interest
Resource type:
Select a resource type
Please select an area of interest first
Search:

SCTO Tools & Resources Navigator *

Search Results (120)
Sort by: 10 per page
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
The SCTO is actively following developments in AI and clinical research, exploring how the clinical research community navigate the opportunities and challenges they present. To support these efforts, the SCTO has established a new project group dedicated to AI in clinical research, led by Anastasios Stathis. In an exclusive Q&A, he introduces the project and shares his insights into the evolving role of AI in clinical research.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
While existing ethical principles and regulations apply equally to clinical research involving AI, its growing use raises new challenges in oversight, accountability, and governance. Pietro Gervasoni from swissethics these emerging ethical considerations, frameworks for researchers, sponsors, and ethic committees. He also emphasises the importance of ongoing reflection as AI continues to reshape clinical research.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
Artificial intelligence is transforming clinical research in several interconnected ways. While AI offers opportunities to address long-standing challenges and improve research processes, clinical research plays a crucial role in generating the evidence needed to evaluate AI-enabled technologies. At the same time, the increasing use of AI is reshaping the regulatory landscape, highlighting the need for appropriate oversight, robust safeguard, and the protection of research participants.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
Health software serves a wide range of functions and may be classified as a medical device under Swiss and EU legislation if it is intended for a medical purpose. In such cases, it must comply with applicable medical device regulations. The integration of artificial intelligence (AI) into medical device software introduces additional regulatory considerations and challenges. Einat Albers-Schönberg from Swissmedic provides the regulatory authority’s perspective on the use of AI in medical devices, offering insights into this evolving field.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
The increasing use of AI in clinical research raises the question of how patients and the public should be involved in its development and use. Christine Jacob from the European Patients’ Academy on Therapeutic Innovation Switzerland (EUPATI CH) explore the role of patients and the public in the development and use of AI in clinical research. She highlights how their involvement can help ensure that AI technologies deliver meaningful, trustworthy value in real-world research settings.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
AI has the potential to enhance clinical trial management, from assessing trial feasibility and supporting patient recruitment to monitoring trial progress and evaluating outcomes. Lara Bernasconi explores the opportunity and challenges of integrating AI systems into clinical trial management, highlighting ethical blind spots, potential trade-offs, and the importance of interdisciplinary collaboration to ensure their responsible use in clinical research.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
Large Language models (LLMs) are increasingly being use in clinical research, offering potential applications ranging from evidence synthesis and protocol development to data extraction. Benjamin Ineichen explores the opportunity and limitations of these tools, with a particular focus on the challenges of evaluating their performance. He also highlights the gap between the potential capabilities of LLMs and their demonstrated clinical value, underscoring the need for rigorous evaluation before their broader adoption in clinical research.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
Find out more about key regulatory developments, relevant publications, and selected events related to clinical research in Switzerland, Europe, and beyond.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Peer-reviewed article
AI-enabled medical technologies require robust clinical evidence to support their safe and effective use in clinical practice. In this case study, Cyrill Gyger and Jonas Reber introduce their QUMEA’s AI-enabled, radar-based system for contactless patient monitoring. They highlight QUMEA’s distinct approach to product development, in which regulatory requirements were integrated into the design process from the outset, shaping the system’s architecture, capabilities, and market positioning.
See Links & Downloads
Regulatory Affairs | Guidelines & Publications | Article
Issue on Regulatory changes coming from the EU and the ongoing revisions of Swiss laws regarding medical devices.
See Links & Downloads
1 … 6 7 8 9 10 … 12

* Contains only tools and resources developed by the SCTO. SCTO CRC Network services are not included.